Is ABT a good stock to buy? We came across a bullish thesis on Abbott Laboratories on Compounding Dividends’s Substack by TJ ...

Abbott Laboratories stock reached a 52-week low, hitting a price of 105.24 USD, just pennies above its bottom of 105.27 USD. This milestone reflects a challenging period for the h ...

Shares of Abbott Laboratories ABT slipped 1.61% to $105.46 Friday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index SPX falling 1.51% to 6,506.48 ...

The healthcare giant is roughly 22% down from its 52-week high of $139.06 as of writing. However, for investors focused on ...

Recent performance snapshot Abbott Laboratories (ABT) has seen mixed share performance recently, with a modest 0.2% move over the past day and a 1.3% gain over the past week, closing at $114.76. Over ...

This company has delivered earnings and dividend growth over time. Abbott’s innovation and a new acquisition could spur more growth in the years to come. 10 stocks we like better than Abbott ...

Abbott Laboratories’ stock took a direct hit, wiping out nearly 10% of its market value following its Q4 earnings. Response? The CEO bought $2 million shares. Robert B. Ford, CEO of Abbott ...

Abbott Laboratories' (NYSE: ABT) January 2026 price pullback is making its stock look attractively valued. The move, driven more by market angst and fear than by any real weaknesses, seems to be a ...

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current ...

Detailed price information for Abbott Laboratories (ABT-N) from The Globe and Mail including charting and trades.

Abbott (ABT) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Over ...